Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

132012AssetsCash, cash equivalents and marketable securities 1

$
511,247$
317,114Other current assets 2

21,41629,378Total current assets

532,663346,492Property and equipment, net

9,4786,403Other assets

3,0202,234Total assets

$
545,161$
355,129Liabilities and Stockholders' EquityDeferred revenue - current portion

$
8,036$
8,139Other current liabilities

39,35321,118Total current liabilities

47,38929,257Deferred revenue - non-current portion

59,87962,562Deferred rent

783784Total liabilities

108,05192,603Stockholders' equity

437,110262,526Total liabilities and stockholders' equity

$
545,161$
355,1291 Marketable securities

$
8,721$
9,6812 As of March 31, 2013 and December 31, 2012, Other current assets includes $17.1 million and $26.6 million, respectively, due to the Company from Janssen under the collaboration and license agreement.

Pharmacyclics, Inc.Condensed Consolidated Statements of Operations
(unaudited; in thousands, except per share data)

Three Months EndedMar. 31,Mar. 31,20132012Revenue:  License and milestone revenue

$
-$
-  Collaboration services revenue

2,8461,927Total revenue

2,8461,927Operating expenses*:  Research and Development

35,78415,828  General and Administrative

20,0264,061Total operating expenses

55,81019,889Loss from operations

(52,964)(17,962)Interest and other income, net

7956Loss before income taxes

(52,885)(17,906)Income tax benefit

9745,083Net loss

$
(51,911)$
(12,823)Net loss per share:Basic

$
(0.73)$
(0.19)Diluted

$

'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014  RXi ... biotechnology company focused on discovering, developing and commercializing ... RNA-targeted technologies, today announced completion of enrollment in its ... from the 3-month observations confirmed the 1-month findings ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind alle ... SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ 2015 ... besuchen. Diese Tagung soll dazu ... Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, die ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
(Date:12/20/2014)... 2014 Parker & Sons, Inc. a ... of experience in contractor services announces reaching a milestone ... the homeowners of Arizona. Parker and Sons is comprised ... technicians that make customer service the number one priority. ... and started with one service vehicle and has since ...
(Date:12/19/2014)... It’s very easy to become overwhelmed with the holidays ... the wayside until Christmas and the New Year are over. ... that burning desire to just escape it all and get ... Telluride with a no-fuss, affordable package. Montrose Days Inn will ... and ensure that all accommodations are met. Plus, everyone has ...
(Date:12/19/2014)... FL (PRWEB) December 19, 2014 ... Revitalizing Bedsheets are now available. Celliant, the world’s ... both sheets and pillowcases. , There are a ... proven additional circulation, increased oxygenation and balanced body ... faster healing and pain relief; enhanced athletic performance; ...
(Date:12/19/2014)... SuperCloset raises the bar once again, ... to offer indoor growers the most efficient and effective ... SuperClone Rooms with the award winning SuperRooms ... grow room setup. , The SuperClone Room features the ... SuperCloner 50 . The SuperClone Room pairs ...
(Date:12/19/2014)... An evening dress is perfect for any occasion and is ... dresses retailer, has unveiled its new selection of evening dresses. ... shopping platform. Customers can view more at its ... been accepted and praised by customers for many years. It ... clients. In order to expand its market share, the company ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2
... Living Hope Health Fair ... County is being hosted by Living Hope Church on the Brush Prairie campus Feb. 26 from ... dads will all find fun and information at Hope 4 a Healthier You. , ... (PRWEB) February 20, 2010 -- The largest and most ...
... ... ... , ... ...
... ... ... ... ...
... Loyola University Medical Center ranked among the top hospitals ... pathologists in training. Loyola was tied for the ... accepted in the Stowell-Orbison Awards competition sponsored by the ... hundred academic programs worldwide participated in the competition. ...
... work, but application remains years away , FRIDAY, Feb. 19 ... to hint that gene therapy could become a weapon against ... far from being ready for use by patients, and would ... "a step in the direction of using gene therapy" to ...
... ... ... ... ...
Cached Medicine News:Health News:Vancouver, Washington -- Free Family Fun at Health Fair 2Health News:California Dental Association Foundation Expands Care to State's Underserved Communities 2Health News:California Dental Association Foundation Expands Care to State's Underserved Communities 3Health News:California Dental Association Foundation Expands Care to State's Underserved Communities 4Health News:California Dental Association Foundation Expands Care to State's Underserved Communities 5Health News:Idaho Legislators Stand for Health Care Freedom 2Health News:Idaho Legislators Stand for Health Care Freedom 3Health News:Idaho Legislators Stand for Health Care Freedom 4Health News:Gene Therapy Shows Promise Against HIV 2Health News:Health Groups Ask Supreme Court to Authorize Financial Penalties on Tobacco Companies for Decades of Wrongdoing 2Health News:Health Groups Ask Supreme Court to Authorize Financial Penalties on Tobacco Companies for Decades of Wrongdoing 3
... analyzer is an affordable system offering ... reliability and consistency of state-of-the-art instrument-based ... way to obtain dependable urine chemistry ... economy of motion and superior efficiency ...
... device consists of a non-compliant balloon with ... longitudinally on its outer surface. When the ... atherotomes score the plaque, creating initiation sites ... as Atherotomy, allows dilatation of the target ...
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
Medicine Products: